These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1948898)

  • 1. [Urogenital estrogen deficiency syndrome. Investigation and treatment with special reference to hormone substitution].
    Eriksen BC; Hunskår S
    Tidsskr Nor Laegeforen; 1991 Oct; 111(24):2949-51. PubMed ID: 1948898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.
    Santos I; Clissold S
    Gynecol Endocrinol; 2010 Sep; 26(9):644-51. PubMed ID: 20374067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urogenital estrogen deficiency symptoms. Too few elderly women receive any treatment].
    Lisper B; Nordenstam I; Wessling A
    Lakartidningen; 1993 Dec; 90(49):4451-2. PubMed ID: 8271889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urogenital atrophy and recurrent urinary tract infection in elderly patients].
    Salvat J; Capilna M; Schmidt MH
    Praxis (Bern 1994); 1997 Aug; 86(33):1249-53. PubMed ID: 9381010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical and surgical strategies for treating urogynecological disorders.
    Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(2):136-41. PubMed ID: 8829692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal oestrogen therapy after breast cancer: is it safe?
    Ponzone R; Biglia N; Jacomuzzi ME; Maggiorotto F; Mariani L; Sismondi P
    Eur J Cancer; 2005 Nov; 41(17):2673-81. PubMed ID: 16239103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
    Koloszár S; Kovács L
    Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Menopausal estrogen therapy has a beneficial effect on quality of life].
    Wiklund I
    Lakartidningen; 1999 Mar; 96(13):1582-5. PubMed ID: 10218340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
    Archer DF
    Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urogenital complaints: value of systemic estrogen therapy].
    Hänggi W; Dörflinger A
    Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urogenital atrophy.
    Calleja-Agius J; Brincat MP
    Climacteric; 2009 Aug; 12(4):279-85. PubMed ID: 19387880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal changes in aging from the viewpoint of the gynecologist].
    Wolf AS
    Fortschr Med; 1991 Jun; 109(18):374-8. PubMed ID: 1916554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.
    Nappi RE; Davis SR
    Climacteric; 2012 Jun; 15(3):267-74. PubMed ID: 22612614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.